Skip to main content
construction release_alert
Scholars@Duke will be undergoing maintenance April 11-15. Some features may be unavailable during this time.
cancel
Journal cover image

Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma

Publication ,  Conference
Cuneo, KC; Vredenburgh, J; Desjardins, A; Peters, K; Sampson, J; Allen, K; Chang, Z; Duffy, E; Peterson, B; Kirkpatrick, JP
Published in: International Journal of Radiation Oncology*Biology*Physics
November 2012

Duke Scholars

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2012

Volume

84

Issue

3

Start / End Page

S7 / S7

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Cuneo, K. C., Vredenburgh, J., Desjardins, A., Peters, K., Sampson, J., Allen, K., … Kirkpatrick, J. P. (2012). Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. In International Journal of Radiation Oncology*Biology*Physics (Vol. 84, pp. S7–S7). Elsevier BV. https://doi.org/10.1016/j.ijrobp.2012.07.024
Cuneo, K. C., J. Vredenburgh, A. Desjardins, K. Peters, J. Sampson, K. Allen, Z. Chang, E. Duffy, B. Peterson, and J. P. Kirkpatrick. “Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma.” In International Journal of Radiation Oncology*Biology*Physics, 84:S7–S7. Elsevier BV, 2012. https://doi.org/10.1016/j.ijrobp.2012.07.024.
Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, et al. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. In: International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S7–S7.
Cuneo, K. C., et al. “Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma.” International Journal of Radiation Oncology*Biology*Physics, vol. 84, no. 3, Elsevier BV, 2012, pp. S7–S7. Crossref, doi:10.1016/j.ijrobp.2012.07.024.
Cuneo KC, Vredenburgh J, Desjardins A, Peters K, Sampson J, Allen K, Chang Z, Duffy E, Peterson B, Kirkpatrick JP. Impact of Concurrent and Adjuvant Bevacizumab on the Risk of Radiation Necrosis Following Radiosurgery for Recurrent Glioma. International Journal of Radiation Oncology*Biology*Physics. Elsevier BV; 2012. p. S7–S7.
Journal cover image

Published In

International Journal of Radiation Oncology*Biology*Physics

DOI

ISSN

0360-3016

Publication Date

November 2012

Volume

84

Issue

3

Start / End Page

S7 / S7

Publisher

Elsevier BV

Related Subject Headings

  • Oncology & Carcinogenesis
  • 5105 Medical and biological physics
  • 3407 Theoretical and computational chemistry
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
  • 1103 Clinical Sciences
  • 0299 Other Physical Sciences